Objectives Measuring urinary cotinine is a popular and established method of biologically monitoring exposure to tobacco smoke. However, the lower detection limit of cotinine often impedes the evaluation of passive (second-hand) smoking and this, together with unconverted nicotine, does not reflect actual levels of exposure. Furthermore, a portion of the Japanese population might have decreased ability to metabolize nicotine. The present study was therefore carried out to validate the simultaneous analysis of total concentrations of free nicotine and cotinine and their glucuronides to determine actual levels of voluntary and involuntary exposure to cigarette smoke. Methods Urine samples from 118 Japanese smokers and 117 non-smokers were analyzed using gas chromatography-mass spectrometry. Voluntary and involuntary smoking status was self-reported and workplace smoking restrictions were objectively evaluated.
Introduction
Cotinine can be detected in various biological samples including urine, blood, hair, and saliva. Measuring cotinine concentrations in such samples is the most popular methodology for evaluating exposure to tobacco smoke [1] . Various chromatographic techniques (e.g., ultraperformance liquid chromatography [UPLC], liquid chromatography [LC]/mass spectrometry [MS]/MS, gas chromatographymass spectrometry [GCMS] ) and immunoassays [2] [3] [4] [5] [6] have been applied to determine exposure to tobacco smoke, and some of these methods have also been applied practically in epidemiological studies [7] [8] [9] [10] . For example, Yuan and colleagues found that urinary cotinine levels were associated with lung cancer development in smokers [8] . In addition, low levels of urinary cotinine resulting from exposure to second-hand smoke are inversely correlated with respiratory function [10] .
Nicotine, cotinine, and their glucuronides are the major chemical species that are detectable after exposure to cigarette smoke (Fig. 1) . In the present study we analyzed urine samples from 235 Japanese workers including 117 non-smokers to validate our analytical procedure and to examine correlations between urinary nicotine and cotinine values and smoking (active and passive).
A relatively short half-life (a few hours) has rendered measuring nicotine levels of little value in terms of assessing exposure to cigarette smoke. In contrast, the halflife of cotinine is approximately 20 h [11] . Here, we simultaneously measured nicotine and cotinine because the procedure is straightforward [12, 13] and half of all Japanese individuals have low activity of cytochrome P450 2A6 (CYP2A6), which is needed to metabolize nicotine to cotinine [14] . Nicotine detection might be useful when individuals have less active CYP2A6 phenotypes.
Although the measurement of total cotinine concentrations is not typical, a few research groups have applied the technique [5, 8, 15] . Total measurements confer an obvious advantage in that the signal is greater relative to that of free concentrations. The method has been applied with the expectation of a closer correlation with actual exposure rather than that gained by simply measuring levels of free cotinine, as we have previously shown [5] .
Subjects, materials, and methods

Study population
Urine samples were collected at a facility that routinely performs medical examinations at workplaces in Saga, Fig. 1 Nicotine metabolites. Around 80 % of nicotine is oxidized to cotinine, mainly by cytochrome P450 2A6 (CYP 286) [19, 20] . Nicotine and cotinine glucuronides were hydrolyzed to nicotine and cotinine and measured as total nicotine and cotinine (sum of free compound and glucuronides) Differences determined by t-test using logarithms; 0.28 ng/mL, detection limit of nicotine/H2 was applied to data below detection limits ( Another group of spot urine samples taken from 219 individuals (age range, 18-60 years) in 2008 and stored at -20°C were analyzed in 2008. Information regarding the smoking habits of the participants and their family members was obtained from questionnaires administered at the time of sample collection. The study participants were employed by 11 subcontractors of a manufacturing company. The subcontractors were located at adjacent sites but each had different policies regarding smoking in the workplace and in the immediate environment surrounding the workplace. Smoking restriction status was verified by interviews and inspections by an occupational physician. Among the 219 individuals in this group, 117 were nonsmokers (female, n = 59) and 102 were smokers (female, n = 16). The subcontractors were engaged in various industries including ironworks and transport.
Sample analysis
Sample preparation and GC-MS analysis proceeded as described [5] . Diphenylamine (internal standard
Creatinine levels were measured using a Creatinine Assay kit (Cayman Chemical Company, Ann Arbor, MI, USA) to normalize urine concentrations.
Results
Comparison of free and total values
Regression coefficients indicated that total nicotine and cotinine concentrations were 1.2-and 2.4-fold higher relative to the free values (Fig. 2) . The integrated sum of all concentrations revealed 2.2-and 2.4-fold higher total levels of nicotine and cotinine relative to the free levels. When free nicotine was measured, eight samples were below the LLOQ, while one sample was below the LLOQ for cotinine measurement. In comparison, two and zero samples were below the LLOQ when total nicotine and total cotinine, respectively, were evaluated.
Total nicotine and cotinine levels in 219 employees
Smokers showed higher nicotine and cotinine levels than non-smokers (Table 1) . Among smokers, male subjects showed significantly higher nicotine and cotinine levels than female subjects, whereas there was no clear difference between the sexes among non-smokers ( Table 1 ). The secretion ratios of nicotine and cotinine differed significantly between smokers and non-smokers (Table 1) . Scatter plots of individual distributions showed that 21 % of smokers and 54 % of non-smokers had greater urinary nicotine than cotinine levels (nicotine:cotinine [1) (Fig. 3) . Moreover, 5 and 37 % of smokers and non- smokers, respectively, had nicotine levels that were two or more times greater than cotinine levels (nicotine:cotinine [2) . The accumulated sum of all samples showed 1.8-fold higher cotinine than nicotine levels in smokers, and the same levels of both in non-smokers. Both nicotine and cotinine concentrations were strongly correlated with the numbers of cigarettes smoked per day (Fig. 4) . Data from non-smokers were obviously affected by workplace policies prohibiting smoking and whether or not anyone smoked at home. Nicotine values indicated a clearer environmental effect than cotinine alone (Fig. 5) .
Discussion
The present study showed that the simultaneous analysis of total nicotine and cotinine was useful for biologically monitoring active and passive smoking. Nicotine and cotinine were simply detected with a single GC-MS run [12] . Although an extra hour was required to deglucuronidate urine samples, total values of urinary nicotine and cotinine were high, which was particularly advantageous for analyzing samples from non-smokers.
Total nicotine and cotinine were closely correlated with active and passive smoking. The present protocol confers less benefit upon analyses of urine from smokers, because levels of metabolites are high enough to detect, and the main metabolite cotinine reflects smoking status more accurately than nicotine. In contrast, average urinary nicotine and cotinine levels were the same in non-smokers, and some samples contained high nicotine and low cotinine levels, indicating that simultaneous measurement generates meaningful data from non-smokers.
Benowitz and colleagues showed that 7 and 6 % of nicotine and its glucuronide, respectively, were excreted and 17 and 15 % of cotinine and its glucuronide, respectively, were excreted within 24 h [19] . Consequently, the theoretical total nicotine/total cotinine ratio is 0.4, which is compatible with the present median finding in smokers of 0.42. However, in the present study, the median nicotine/ cotinine ratio of 1.22 was significantly higher in nonsmokers than smokers. A study of 959 urine samples from Malaysian university students also found significantly higher nicotine levels in non-smokers than in smokers [13] .
The explanation for this might be associated with the half-lives of nicotine and cotinine and the time of urine collection. For example, if the employees in our study had been exposed to second-hand tobacco smoke in the workplace within a few hours before the urine sampling, the nicotine concentration in their urine would have risen because the nicotine would not yet have been metabolized to cotinine. An increased nicotine concentration would have a big impact in urine samples from non-smokers, but not in the urine samples from smokers, because they would already have had high concentrations of nicotine and cotinine in their urine.
Different CYP2A6 polymorphisms among individuals of different ethnicity provide another possible reason for significantly higher nicotine levels in non-smokers than in smokers. According to Nakajima and colleagues, 9, 22, 43, and 51 % of Caucasian, Black, Korean, and Japanese populations have a CYP2A6 polymorphism that results in slow nicotine metabolism [14] . Because CYP2A6 activity correlates with cigarette consumption [16] [17] [18] , Asian nonsmokers might have lower CYP2A6 activity than nonsmokers in other ethnic groups.
Thus, the present findings indicate that the simultaneous analysis of total nicotine and cotinine is simple and useful for tobacco smoke monitoring especially for non-smokers with lower CYP2A6 activity. However, a major limitation of this study is the lack of genotype information. The association between the usefulness of nicotine monitoring and CYP2A6 polymorphism needs to be proven by further research involving actual genotyping. Another concern might be the volatility of nicotine. As urine samples were incubated at 75°C for 1 h for deglucuronidation, artifactual loss could have occurred more in nicotine than in cotinine, based on Henry's Law constant (3.0 9 10 -9 and 3.3 9 10 -12 atm-m 3 /mole, respectively) (http://www.ncbi. nlm.nih.gov/pccompound). We previously reported that adjusting urinary cotinine values according to the creatinine concentration was possibly ineffective with urine samples from children [5] ; however, in the present study, the creatinine-adjusted nicotine and cotinine concentrations showed stronger correlation with active/passive smoking status than the unadjusted data, which indicates the adjustment is meaningful with adult urine.
In conclusion, the simultaneous measurement of total urinary nicotine and cotinine is useful particularly among non-smokers with higher urinary nicotine than cotinine, such as individuals with CYP2A6 polymorphisms. 
